BR112012024206A2 - método e sistema para analisar uma amostra de sangue - Google Patents

método e sistema para analisar uma amostra de sangue

Info

Publication number
BR112012024206A2
BR112012024206A2 BR112012024206A BR112012024206A BR112012024206A2 BR 112012024206 A2 BR112012024206 A2 BR 112012024206A2 BR 112012024206 A BR112012024206 A BR 112012024206A BR 112012024206 A BR112012024206 A BR 112012024206A BR 112012024206 A2 BR112012024206 A2 BR 112012024206A2
Authority
BR
Brazil
Prior art keywords
blood sample
analyzing
methods
blood
analysis
Prior art date
Application number
BR112012024206A
Other languages
English (en)
Other versions
BR112012024206B8 (pt
BR112012024206B1 (pt
Inventor
Christophe P Godefroy
John Steven Riley
Patricio J Vidal
Original Assignee
Beckman Coulter Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beckman Coulter Inc filed Critical Beckman Coulter Inc
Publication of BR112012024206A2 publication Critical patent/BR112012024206A2/pt
Publication of BR112012024206B1 publication Critical patent/BR112012024206B1/pt
Publication of BR112012024206B8 publication Critical patent/BR112012024206B8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
    • G01N15/1459—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals the analysis being performed on a sample stream
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N2015/1006—Investigating individual particles for cytology
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • Ecology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

m´petodo e sistema para analisar uma amostra de sangue. métodos, sistemas, e produtos de programa de computador para a análise de uma amostra de sangue são revelados. uma concretização é um método de detectar e enumerar células difíceis de remover hemoglobina em uma amostra de sangue. outras concretizações é um método de analisar reticulócitos em uma amostra de sangue. métodos de uso de parâmetros de contagem de sangue são também proprocionados.
BR112012024206A 2010-03-24 2010-03-25 método de detecção de células difíceis de remover hemoglobina, e método automático de quantificar células difíceis de remover hemoglobina BR112012024206B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/730,977 US8603773B2 (en) 2008-09-19 2010-03-24 Method and system for analyzing a blood sample
US12/730,977 2010-03-24
PCT/US2010/028683 WO2011119163A1 (en) 2010-03-24 2010-03-25 Method and system for analyzing a blood sample

Publications (3)

Publication Number Publication Date
BR112012024206A2 true BR112012024206A2 (pt) 2016-07-05
BR112012024206B1 BR112012024206B1 (pt) 2020-12-22
BR112012024206B8 BR112012024206B8 (pt) 2021-07-27

Family

ID=44673500

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012024206A BR112012024206B8 (pt) 2010-03-24 2010-03-25 método de detecção de células difíceis de remover hemoglobina, e método automático de quantificar células difíceis de remover hemoglobina

Country Status (10)

Country Link
US (2) US8603773B2 (pt)
EP (1) EP2561350B1 (pt)
JP (1) JP5762523B2 (pt)
KR (1) KR101847225B1 (pt)
CN (2) CN102822670B (pt)
AU (1) AU2010348992B2 (pt)
BR (1) BR112012024206B8 (pt)
ES (1) ES2641015T3 (pt)
SG (1) SG183828A1 (pt)
WO (1) WO2011119163A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8603773B2 (en) 2008-09-19 2013-12-10 Beckman Coulter Method and system for analyzing a blood sample
WO2012142496A1 (en) 2011-04-15 2012-10-18 Constitution Medical, Inc. Measuring volume and constituents of cells
WO2013019290A2 (en) 2011-04-21 2013-02-07 Streck, Inc. Immature reticulocyte fraction reference control and related methods
KR101963477B1 (ko) 2012-07-05 2019-03-28 베크만 컬터, 인코포레이티드 백혈구 수치를 측정하기 위한 방법 및 장치
BR112015015400A2 (pt) 2012-12-31 2017-07-11 Beckman Coulter Inc métodos e sistemas de enumeração de plaquetas imaturas
WO2014146030A1 (en) * 2013-03-15 2014-09-18 Iris International, Inc. Flowcell systems and methods for particle analysis in blood samples
JP6612050B2 (ja) * 2014-08-28 2019-11-27 シスメックス株式会社 血液分析装置、診断支援方法、およびコンピュータプログラム
WO2016063364A1 (ja) * 2014-10-22 2016-04-28 株式会社日立ハイテクノロジーズ 細胞計測機構及びそれを有する細胞培養装置並びに細胞計測方法
WO2020222417A1 (ko) * 2019-04-29 2020-11-05 사회복지법인 삼성생명공익재단 가압식 검체 샘플링 장치
KR102451165B1 (ko) * 2019-04-29 2022-10-05 사회복지법인 삼성생명공익재단 가압식 검체 샘플링 장치
EP4365570A1 (en) * 2022-11-04 2024-05-08 Horiba, Ltd. Measurement method, measurement system, and test reagent kit

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0698211B1 (en) * 1993-05-14 2003-04-02 Coulter International Corporation Reticulocyte analyzing method and apparatus utilizing light scatter techniques
US6060322A (en) * 1998-10-20 2000-05-09 Coulter International Corp. Method for identification of reticulated cells
JP3074171B1 (ja) * 1999-06-09 2000-08-07 キヤノン販売株式会社 層間絶縁膜の形成方法、及び半導体装置
JP2002148261A (ja) * 2000-11-09 2002-05-22 Sysmex Corp 異常細胞分類計数方法
US6410330B1 (en) * 2001-07-27 2002-06-25 Coulter International Corp. Method for measurement of nucleated red blood cells
US6472215B1 (en) 2001-07-27 2002-10-29 Coulter International Corp. Method of analyzing nucleated red blood cells in a blood sample
JP4354982B2 (ja) * 2002-06-24 2009-10-28 シスメックス株式会社 白血球の分類計数方法
US7405082B2 (en) * 2002-09-10 2008-07-29 Sysmex Corporation Methods and devices for measuring reticulocytes
US7208319B2 (en) * 2004-02-10 2007-04-24 Beckman Coulter, Inc. Method of measurement of nucleated red blood cells
WO2005076995A2 (en) * 2004-02-10 2005-08-25 Beckman Coulter, Inc. Method of measurement of nucleated red blood cells
JP4417143B2 (ja) * 2004-03-11 2010-02-17 シスメックス株式会社 試料分析装置、プログラムおよびそのプログラムを記録した記録媒体
US7390662B2 (en) * 2005-11-09 2008-06-24 Beckman Coulter, Inc. Method and apparatus for performing platelet measurement
US7541190B2 (en) * 2005-02-07 2009-06-02 Beckman Coulter, Inc. Method of measurement of cellular hemoglobin
US7344890B2 (en) * 2005-11-09 2008-03-18 Beckman Coulter, Inc. Method for discriminating platelets from red blood cells
US7354767B2 (en) * 2006-03-16 2008-04-08 Beckman Coulter, Inc. Reference control composition containing a nucleated red blood cell component made of non-nucleated blood cells
JP4976038B2 (ja) * 2006-03-29 2012-07-18 シスメックス株式会社 血液学的試料の測定方法
FR2933192B1 (fr) * 2008-06-25 2010-09-17 Horiba Abx Sas Dispositif et procede de mesure electro optique destines a la classification et au comptage d'elements microscopiques.
US8603773B2 (en) 2008-09-19 2013-12-10 Beckman Coulter Method and system for analyzing a blood sample
US8512977B2 (en) * 2008-09-19 2013-08-20 Beckman Coulter, Inc. Analyzing reticulocytes
JP4969596B2 (ja) * 2009-02-04 2012-07-04 シスメックス株式会社 試料分析装置、試料分析方法およびプログラム
US9658215B2 (en) * 2011-04-07 2017-05-23 Beckman Coulter, Inc. Identifying and enumerating early granulated cells (EGCs)

Also Published As

Publication number Publication date
BR112012024206B8 (pt) 2021-07-27
BR112012024206B1 (pt) 2020-12-22
US20100240055A1 (en) 2010-09-23
CN102822670B (zh) 2014-11-05
SG183828A1 (en) 2012-10-30
CN102822670A (zh) 2012-12-12
WO2011119163A8 (en) 2011-11-17
AU2010348992B2 (en) 2016-06-09
ES2641015T3 (es) 2017-11-07
AU2010348992A1 (en) 2012-09-27
WO2011119163A1 (en) 2011-09-29
US20140065665A1 (en) 2014-03-06
EP2561350A1 (en) 2013-02-27
EP2561350B1 (en) 2017-06-28
EP2561350A4 (en) 2014-03-05
KR20130018405A (ko) 2013-02-21
KR101847225B1 (ko) 2018-04-09
US8603773B2 (en) 2013-12-10
CN104280537A (zh) 2015-01-14
JP5762523B2 (ja) 2015-08-12
JP2013522644A (ja) 2013-06-13
US8877460B2 (en) 2014-11-04

Similar Documents

Publication Publication Date Title
BR112012024206A2 (pt) método e sistema para analisar uma amostra de sangue
WO2014028378A3 (en) Methods and systems for detecting biological components
WO2014015194A3 (en) Methods for detecting and measuring aggregation
EP2703813A4 (en) BLOOD ANALYZER, BLOOD ANALYSIS METHOD, AND COMPUTER PROGRAM
BR112013022735A2 (pt) aparelho para processamento de uma amostra, aparelho para processamento de uma pluralidade de amostras, método para detectar a presença ou ausência de um analito em uma amostra e método para detectar a presença ou ausência de um analito em uma pluralidade de amostras
ZA201306705B (en) Method and system for portable cell detection and analysis using microfluidic technology
EP2749868A4 (en) SINGLE PARTICLE DETECTOR WITH OPTICAL ANALYSIS, SINGLE PARTICLE PROCESSING WITH IT AND COMPUTER PROGRAM FOR SINGLE PARTICLE DETECTION
EP2375244A4 (en) Blood coagulation system analyzer, and blood coagulation system analysis method and program
WO2012024658A3 (en) Integrated analysis system
BR112014010696A2 (pt) método para identificar uma molécula de analito em uma amostra biológica, sensor para capturar um analito de interesse de uma amostra biológica, e, detector
WO2013070756A3 (en) System and method for processing samples
WO2011116006A3 (en) A rapid method to measure cyanide in biological samples
WO2014028648A3 (en) System and method for forming predictions using event-based sentiment analysis
WO2012159021A3 (en) Portable hemostasis analyzer
AU2012262364A8 (en) Systems and methods for genetic and biological analysis
EP3070478A4 (en) Analyte testing automation system, biological sample check module, and biological sample check method
EP2501499A4 (en) Apparatus, systems, and methods adapted to rinse and dry clinical analyzer sample probes
CR20110567A (es) Dispositivos para diagnostico y metodos relacionados
WO2012094227A3 (en) Systems and methods for sample analysis
EP2749867A4 (en) OPTICAL ANALYZER USING DETECTION OF LIGHT EMITTING PARTICLES, OPTICAL ANALYSIS METHOD, AND COMPUTER PROGRAM USED FOR OPTICAL ANALYSIS
BRPI0916111A2 (pt) cubeta para armazenar uma amostra biol[ogica a ser analisada por meio de uma técnica de detecção pré definida, método para a fabricação de uma cubeta, método para autenticar uma cubeta, método para analisar uma amostra biológica e sistema para analisar uma amostra biológica
BR112015009901A2 (pt) elementos de ensaio , material reagente e método para a determinação dos primeiro e segundo analitos em uma amostra.
EA201291396A1 (ru) Способ детекции молекулярных взаимодействий
WO2009126848A3 (en) Analyzing large data sets using a computer system
EP2672270A4 (en) Specimen analysis system, specimen analysis device, and specimen analysis method

Legal Events

Date Code Title Description
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/12/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/03/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 12A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2663 DE 18-01-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.